Residence in Peripheral Regions and Low Socioeconomic Status Are Associated With Worse Outcomes of Inflammatory Bowel Diseases: A Nationwide Study From the epi-IIRN

Oren Ledder, MD,*,†, Sasha Harel, MA,* Rona Lujan, MA,* Chagit Friss, BSc,* Esther Orlanski-Meyer, MD,* Dotan Yogev, MD,*, Yiska Loewenberg Weisband, MD, ‡ Shira Greenfeld, MD, § Revital Kariv, MD,§ Natan Lederman, MD, ¶ Eran Matz, MD, || Doron Schwartz, MD,** Gili Focht, MSc,* Iris Dotan, MD, ††,‡‡ and Dan Turner, MD*,†

doi : 10.1093/ibd/izad034

Volume 30, Issue 1, January 2024

Buy The Package and View The Article Online

Prediction of Response to Systemic Corticosteroids in Active UC by Microbial Composition—A Prospective Multicenter Study

Andreas Blesl, MD,*, Philipp Wurm, PhD,*,† Silvio Waschina, MD, ‡, Hans Peter Gr?chenig, MD, § Gottfried Novacek, MD,¶ Christian Primas, MD,¶ Walter Reinisch, MD, ¶ Maximilian Kutschera, MD, ¶ Constanze Illiasch, MD,? Barbara Hennlich, MD,? Pius Steiner, MD,**Robert Koch, MD, †† Wolfgang Tillinger, MD,‡‡ Thomas Haas, MD, §§ Gerhard Reicht, MD,¶¶ Andreas Mayer, MD,?? Othmar Ludwiczek, MD,*** Wolfgang Miehsler, MD,††† Karin Steidl, MD,§ Lukas Binder, MD,* Simon Reider, MD,‡‡‡,§§§ Christina Watschinger, MSc, ‡‡‡,§§§ Stefan Fürst, MD,* Patrizia Kump, MD,* Alexander Moschen, MD, ‡‡‡,§§§ Konrad Aden, MD, ¶¶¶,??? Gregor Gorkiewicz, MD, † and Christoph H?genauer, MD, * on behalf of the Austrian IBD study group (ATISG)

doi : 10.1093/ibd/izad126

Buy The Package and View The Article Online

Efficacy and Tolerance of Thalidomide in Patients With Very Early Onset Inflammatory Bowel Disease

Matteo Bramuzzo, MD,*, Fabiola Giudici, PhD,† Serena Arrigo, MD,‡ Paolo Lionetti, MD, §, Giovanna Zuin, MD,¶ Claudio Romano, MD,? Francesco Graziano, MD,**, Simona Faraci, MD, †† Patrizia Alvisi, MD,‡‡ Sara Signa, MD, ‡ Luca Scarallo, MD,§ Stefano Martelossi, MD, §§ and Grazia Di Leo, MD

doi : 10.1093/ibd/izad018

Buy The Package and View The Article Online

Assessing the Impact of COVID-19 on IBD Outcomes Among Vulnerable Patient Populations in a Large Metropolitan Center

Florence-Damilola Odufalu, MD,*, Justin L. Sewell, MD, PhD, MPH,† Vivek Rudrapatna, MD, PhD, ‡ Ma Somsouk, MD, MAS,†,§, Uma Mahadevan, MD

doi : 10.1093/ibd/izad041

Buy The Package and View The Article Online

Proton pump Inhibitors and Risk of Enteric Infection in Inflammatory Bowel Disease: A Self-controlled Case Series

Sanskriti Varma, MD,*, Stephen J. Trudeau, BS,† Jianhua Li, MS,‡ and Daniel E. Freedberg, MD, MS

doi : 10.1093/ibd/izad035

Buy The Package and View The Article Online

Risk of Tuberculosis and Hepatitis B Reactivation in Patients With Crohn’s Disease on Ustekinumab: A Nationwide Real-World Study

Rongbei Liu, MD,*,†,a, Zhilun Li, MSc,‡,a Lingna Ye, MD,*,† Jing Hu, MD, § Jian Tang, MD,¶,||, Baili Chen, MD, PhD,** Xiuli Chen, MD,†† Bei Tan, MD, PhD, ‡‡ Yubei Gu, MD, §§ Chen Xie, MD, ¶¶ Chunhui Ouyang, MD, PhD,|||| Xiaomei Song, MD*** Fan Li, MM,††† Yanyun Fan , MD,‡‡‡ Haixia Ren, MM,§§§ Liangru Zhu, MD, PhD, ¶¶¶ Min Chen, MD, |||||| Wenyu Jiang, MD, **** and Qian Cao, MD, PhD

doi : 10.1093/ibd/izad032

Buy The Package and View The Article Online

Psychometric Performance of Fatigue Scales in Inflammatory Bowel Disease

Ruth Ann Marrie, MD, PhD,*,†, John D. Fisk, PhD, ‡ Casandra Dolovich, MSc,*,§ Lisa M. Lix, PhD,†,§ Lesley A. Graff, PhD,‡,§ Scott B. Patten, MD, PhD, ¶, Charles N. Bernstein, MD*,§ ; for the CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease

doi : 10.1093/ibd/izad038

Buy The Package and View The Article Online

Matching-Adjusted Indirect Comparisons of Filgotinib vs Vedolizumab, Tofacitinib, and Ustekinumab for Moderately to Severely Active Ulcerative Colitis

Xiaoyan Lu, PhD,*, Zheng-Yi Zhou, PhD,† Yiqiao Xin, PhD, † Min-Jung Wang, ScD,† Emma Gray, PhD,† Vipul Jairath, MBChB, DPhil, MRCP, FRCPC, ‡, and James Oliver Lindsay, BMBCh, PhD

doi : 10.1093/ibd/izad037

Buy The Package and View The Article Online

Speaker Diversity and Audience Ratings at a National Inflammatory Bowel Diseases Conference

Alexander Goldowsky, MD,*,#, Roshni Singh, MD,†,# and Alan Moss, MD

doi : 10.1093/ibd/izad042

Buy The Package and View The Article Online

Profiles of Web-based Portal Users with Inflammatory Bowel Disease

Mohamed Noureldin, MD,* Kira L. Newman, MD, PhD,* Peter D. R. Higgins, MS, MD, PhD,* John D. Piette, PhD, †,‡ Kenneth Resnicow, PhD,† Jeremy Louissaint, MD,§ Brooke Kenney, MS,* Jeffrey Berinstein, MD, MS,*, Akbar K. Waljee, MD, MSc*,‡ Ji Zhu, PhD, MS,? and Shirley Cohen-Mekelburg, MD, MS

doi : 10.1093/ibd/izad056

Buy The Package and View The Article Online

Glycolytic Activation of CD14+ Intestinal Macrophages Contributes to the Inflammatory Responses via Exosomal Membrane Tumor Necrosis Factor in Crohn’s Disease

Ziwei Zeng, MD, PhD,*,†,‡,§,a Sijing Cheng, MD, PhD,*,†,‡,¶,a Xuanna Li, MD, PhD,?,a Huashan Liu, MD, PhD,*,†,‡ Jinxin Lin, MD, PhD,*,†,‡ Zhenxing Liang, MD, PhD,*,†,‡ Xuanhui Liu, MD, PhD,*,†,‡ Chao Cao, MD, PhD,**, Shujuan Li, MD, PhD, †† Xiaowen He, MD, PhD,*,†,‡ Liang Kang, MD, PhD,*,†,‡, Xiaojian Wu, MD, PhD,*,†,‡ and Xiaobin Zheng, MD, PhD

doi : 10.1093/ibd/izad117

Buy The Package and View The Article Online

Oral Omilancor Treatment Ameliorates Clostridioides difficile Infection During IBD Through Novel Immunoregulatory Mechanisms Mediated by LANCL2 Activation

Nuria Tubau-Juni, PhD, Josep Bassaganya-Riera, PhD, DVM, Andrew J. Leber, PhD, Sameeksha S. Alva, MS, and Raquel Hontecillas, PhD, DVM

doi : 10.1093/ibd/izad124

Buy The Package and View The Article Online

Excessive Mitochondrial Fission Suppresses Mucosal Repair by Impairing Butyrate Metabolism in Colonocytes

Shi-Chen Fu, MD,*,†,‡,§,# Jun-Yan Qu, MD,*,‡,§,# Li-Xiang Li, MD, PhD,*,‡,§ Xiao-Xiao Yang, MD,*,‡,§ Yan-Qing Li, MD, PhD,*,‡,§ Xiu-Li Zuo, MD, PhD

doi : 10.1093/ibd/izad132

Buy The Package and View The Article Online

Histological Remission Placebo Rates in Ulcerative Colitis Trials: A Systematic Review and Meta-analysis

Michael Youssef, MD,*, Kelly Dong, MD, † So Jeong Lee, MD,* Neeraj Narula, MD, MPH

doi : 10.1093/ibd/izad013

Buy The Package and View The Article Online

The TNF∆ARE Model of Crohn’s Disease-like Ileitis

Amira Metwaly, PhD,* and Dirk Haller, PhD*,†,

doi : 10.1093/ibd/izad205

Buy The Package and View The Article Online

Long-Term Impact of the COVID-19 Pandemic on Inflammatory Bowel Disease Healthcare Utilization: A 2-Year Nationwide Update

Monica E. W. Derks, MD, *,a, Lisa M. A. van Lierop, MD,*,†,a Maarten te Groen, MD,*, Chantal C. H. J. Kuijpers, MD, PhD,‡ Iris D. Nagtegaal, MD, PhD,§, and Frank Hoentjen, MD, PhD

doi : 10.1093/ibd/izad055

Buy The Package and View The Article Online

Increased Risks for Suicide, Self-Harm, Substance Use, and Psychiatric Disorders in Adults With Inflammatory Bowel Disease: A Nationwide Study in the United States From 2007 to 2017

Chung Sang Tse, MD,*, Chien-Hsiang Weng, MD, MPH,†, Michelle Kwon, BS,‡ Courtney Benjamin Wolk, PhD,§ Lily A. Brown, PhD, † §,¶ Kanika Malani, BS, ‡ Samir A. Shah, MD, **,†† and Sean D. Fine, MD, MS

doi : 10.1093/ibd/izad062

Buy The Package and View The Article Online

A Case of Stricturing Crohn’s Disease Treated With Multiple Session Balloon Dilatation and Self-Expandable Metal Stent

Süleyman Sayar and O?uzhan ?ztürk

doi : 10.1093/ibd/izad287

Buy The Package and View The Article Online

The Use of Placebo in Clinical Trials of Inflammatory Bowel Disease

Pavel S. Roshanov, MD, MSc,*,†,‡,§ and Reena Khanna, MD, MSc†,‡,¶,

doi : 10.1093/ibd/izad281

Buy The Package and View The Article Online